Department of Pharmaceuticals notifies Uniform Code for Pharmaceutical Marketing Practices (UCPMP), 2024 and subsequent amendments
Department of Pharmaceuticals notifies Uniform Code for Pharmaceutical Marketing Practices (UCPMP), 2024 (replacing UCPMP, 2015) and subsequently amends it in September 2025 to streamline marketing-expenditure disclosure.
The Department of Pharmaceuticals (Ministry of Chemicals and Fertilizers) notified the Uniform Code for Pharmaceutical Marketing Practices (UCPMP), 2024 on 12.03.2024. UCPMP, 2024 superseded UCPMP, 2015 and introduced revised provisions to strengthen ethical marketing practices by pharmaceutical companies.
The Department of Pharmaceuticals also amended UCPMP, 2024 in September 2025. The amendments focused on streamlining implementation and disclosure requirements by introducing annual reporting on marketing expenditure on the relevant platform.
Background and earlier position
Before UCPMP, 2024, pharmaceutical marketing practices were governed by UCPMP, 2015. UCPMP, 2024 replaced the earlier code and incorporated revised provisions for ethical marketing governance and compliance.